Sightera Biosciences Raises €3 Million In Pre-Seed Funding For AI-Driven Drug Discovery - Pulse 2.0

A biotech startup using AI for drug discovery secured early-stage funding. This could eventually speed up medicine development, but it's still years away from affecting patients.